Check Out the New F1000Research!

Posted on by

F1000Research, an Open Science publishing platform for life scientists, has recently been added to the MSK Library e-Journal collection.  Its hallmarks are:

  • immediate publication
  • transparent refereeing, with open peer-review and user commenting
  • avoiding editorial bias
  • ensuring the inclusion of all source data

The platform features a single-page submission system with an average time to publication of seven days.  F1000 Research publishes a wide variety of articles including, but not limited to, research articles, method articles, study protocols, reviews, systematic reviews, clinical practice articles, research notes and case reports.  Those interested in publication should consult the author guidelines page.

F1000Research can be accessed through our Journal A-Z list.

New NIH Initiative, Decoy Protein, Perjeta and more…

Posted on by

Here are a few highlights of cancer research news that have recently caught my attention:

  • The NIH launched the Exceptional Responders Initiative which aims to study the molecular factors of tumors for better cancer patient responses to drug therapy.
  • A study by researchers at Vanderbilt found that the use of FDG-PET Technology was less reliable in certain geographic locations where fungal lung disease is more prevalent. For more, see the article in JAMA.
  • Scientists at Stanford developed a decoy protein to stop cancer from spreading. Results are published in the latest issue of Nature Chemical Biology.
  • Chemo and radiation are safe for babies in the womb according to studies presented at the Annual Congress of the European Society for Medical Oncology.
  • Results of a clinical trial on the drug Perjeta reveals success at prolonging life in advanced breast cancer cases.
  • Women who go up a skirt size every decade between their 20s and their 60s may be at increased risk for breast cancer according to a study published in BMJ Open.

Please feel free to contact Marisol Hernandez to share any comments.